Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes

por Matza, Louis S., Cutts, Katelyn N., Stewart, Katie D., Norrbacka, Kirsi, García-Pérez, Luis-Emilio, Boye, Kristina S.
Publicado 2021

Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER)

por Matza, Louis S., Boye, Kristina S., Stewart, Katie D., Coyne, Karin S., Wullenweber, Paula K., Cutts, Katelyn N., Jordan, Jessica B., Wang, Qianqian, Yu, Maria, Currie, Brooke M., Malley, Karen G., Ishak, K. Jack, Hietpas, Ryan T., García‐Pérez, Luis‐Emilio
Publicado 2019